GL1X · GenesisL1 explorer

MolNFT v1 · #73319 · protein

X-ray structure of ester chemical analogue [O-GLY51,O-GLY51']HIV-1 protease complexed with mvt-101 inhibitor

3NYG: “X-ray structure of ester chemical analogue [O-GLY51,O-GLY51']HIV-1 protease complexed with mvt-101 inhibitor”. X-ray diffraction, 3 ligands (GOA, 2NC, SO4), 1 pocket (best druggability 0.71). MolNFT v1 #73319 on GenesisL1: 3D…

PDB
3NYG
Type
protein
Length
196 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
Ligands
GOA, 2NC, SO4
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein984% helix, 52% strand—

Ligands and binding sites

  • GOA · Glycolic acid · ligand · 2 copies · chains A, B
  • 2NC · N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13620.710.83382NC

Interfaces

1 interface between chains.

  • A–B · 1831 Ų buried · 37 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 modified, 4 covalent (nonstandard, covalent ligand, alkylation).

Compared structures

  • 3NYG · X-ray structure of ester chemical analogue [O-Gly51,O-Gly51']HIV-1 protease complexed… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.